Pathstone Family Office’s BioNTech BNTX Stock Holding History

Pathstone Family Office’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$217K	Buy	+1,997	New	+$221K	﹤0.01%	1467
2023 Q2	–	Sell	-1,833	Closed	-$228K	–	1249
2023 Q1	$228K	Sell	1,833 -372	-17%	-$51.1K	﹤0.01%	1035
2022 Q4	$331K	Buy	2,205 +103	+5%	+$15.8K	0.01%	879
2022 Q3	$284K	Buy	2,102 +539	+34%	+$82.4K	0.01%	950
2022 Q2	$233K	Sell	1,563 -386	-20%	-$59K	0.01%	894
2022 Q1	$332K	Buy	1,949 +280	+17%	+$47K	0.01%	708
2021 Q4	$430K	Buy	1,669 +259	+18%	+$70.9K	0.01%	604
2021 Q3	$385K	Buy	1,410 +18	+1%	+$5.72K	0.01%	597
2021 Q2	$312K	Buy	+1,392	New	+$263K	0.01%	631
2021 Q1	–	Sell	-200	Closed	-$16K	–	748
2020 Q4	$16K	Sell	200 -100	-33%	-$9.82K	﹤0.01%	756
2020 Q3	$21K	Buy	300 +100	+50%	+$7.17K	﹤0.01%	469
2020 Q2	$13K	Buy	+200	New	+$9.99K	﹤0.01%	478

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.72B AUM 7.92% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Pathstone Family Office's BNTX Position: Q3 2023 in Review

Pathstone Family Office opened a new position in BioNTech (BNTX) in Q3 2023: 1,997 shares worth $217K. The stake represents ﹤0.01% of the portfolio and ranks #1467 among its holdings. This is a return to the name: Pathstone Family Office previously reported a position in BNTX as recently as Q1 2023.

Pathstone Family Office first reported a position in BNTX in Q2 2020 and has held it in 12 quarters since. The position peaked at $430K in Q4 2021. 251 funds tracked by Wall St. Rank hold BNTX as of Q3 2023.

Pathstone Family Office held 1,997 shares of BioNTech worth $217K as of Q3 2023.
BioNTech was a new Pathstone Family Office position in Q3 2023.
BioNTech made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1467 holding.
Pathstone Family Office first reported a position in BioNTech in Q2 2020 and has held it in 12 quarters since.
Pathstone Family Office's BioNTech position peaked at $430K in Q4 2021.
251 funds tracked by Wall St. Rank held BioNTech as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.